1
|
Steven H, Elias, Campo NancyLee, Harris,
et al: International Agency for Research on Cancer Lyon. WHO
Classification of Tumours of Haematopoietic and Lymphoid Tissues.
1762008.
|
2
|
Thomas DA, O'Brien S, Cortes J, Giles FJ,
Faderl S, Verstovsek S, Ferrajoli A, Koller C, Beran M, Pierce S,
et al: Outcome with the hyper-CVAD regimens in lymphoblastic
lymphoma. Blood. 104:1624–1630. 2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Marks DI, Paietta EM, Moorman AV, Richards
SM, Buck G, DeWald G, Ferrando A, Fielding AK, Goldstone AH,
Ketterling RP, et al: T-cell acute lymphoblastic leukemia in
adults: Clinical features, immunophenotype, cytogenetics, and
outcome from the large randomized prospective trial (UKALL XII/ECOG
2993). Blood. 114:5136–5145. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Pileri SA, Ascani S, Cox MC, Campidelli C,
Bacci F, Piccioli M, Piccaluga PP, Agostinelli C, Asioli S, Novero
D, et al: Myeloid sarcoma: Clinico-pathologic, phenotypic and
cytogenetic analysis of 92 adult patients. Leukemia. 21:340–350.
2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chen X, Rutledge JC, Wu D, Fang M, Opheim
KE and Xu M: Chronic myelogenous leukemia presenting in blast phase
with nodal, bilineal myeloid sarcoma and T-lymphoblastic lymphoma
in a child. Pediatr Dev Pathol. 16:91–96. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Verma RS and Lubs HA: A simple R banding
technic. Am J Hum Genet. 27:110–117. 1975.PubMed/NCBI
|
7
|
Borowitz MJ and Chan JKC: T lymphoblastic
leukaemia/lymphomaSwerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri
SA, Stein H, et al: WHO classification of tumours of haematopoietic
and lymphoid tissues. 4th edition. IARC Press; Lyon: pp. 176–178.
2008
|
8
|
Takahashi H, Koh K, Kato M, Kishimoto H,
Oguma E and Hanada R: Acute myeloid leukemia with mediastinal
myeloid sarcoma refractory to acute myeloid leukemia therapy but
responsive to L-asparaginase. Int J Hematol. 96:136–140. 2012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Bejar R, Lord A, Stevenson K, Bar-Natan M,
Pérez-Ladaga A, Zaneveld J, Wang H, Caughey B, Stojanov P, Getz G,
et al: TET2 mutations predict response to hypomethylating agents in
myelodysplastic syndrome patients. Blood. 124:2705–2712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Bain BJ and Fletcher SH: Chronic
eosinophilic leukemias and the myeloproliferative variant of the
hypereosinophilic syndrome. Immunol Allergy Clin North Am.
27:377–388. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Metzgeroth G, Walz C, Score J, Siebert R,
Schnittger S, Haferlach C, Popp H, Haferlach T, Erben P, Mix J, et
al: Recurrent finding of the FIP1L1-PDGFRA fusion gene in
eosinophilia-associated acute myeloid leukemia and lymphoblastic
T-cell lymphoma. Leukemia. 21:1183–1188. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Tokita K, Maki K, Tadokoro J, Nakamura Y,
Arai Y, Sasaki K, Eguchi-Ishimae M, Eguchi M and Mitani K: Chronic
idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB
chimaera responded to imatinib mesylate therapy. Leukemia.
21:190–192. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pedersen-Bjergaard J, Christiansen DH,
Desta F and Andersen MK: Alternative genetic pathways and
cooperating genetic abnormalities in the pathogenesis of
therapy-related myelodysplasia and acute myeloid leukemia.
Leukemia. 20:1943–1949. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Smith SM, Le Beau MM, Huo D, Karrison T,
Sobecks RM, Anastasi J, Vardiman JW, Rowley JD and Larson RA:
Clinical-cytogenetic associations in 306 patients with
therapy-related myelodysplasia and myeloid leukemia: The university
of Chicago series. Blood. 102:43–52. 2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Abruzzo LV, Jaffe ES, Cotelingam JD,
Whang-Peng J, Del Duca V Jr and Medeiros LJ: T-cell lymphoblastic
lymphoma with eosinophilia associated with subsequent myeloid
malignancy. Am J Surg Pathol. 16:236–245. 1992. View Article : Google Scholar : PubMed/NCBI
|
16
|
Krishnan S, Sabai K, Chuah C and Tan SY:
Bilineal T lymphoblastic and myeloid blast transformation in
chronic myeloid leukemia with TP53 mutation-an uncommon
presentation in adults. Curr Oncol. 21:e147–e150. 2014. View Article : Google Scholar : PubMed/NCBI
|